Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Silent Cerebrovascular Lesion and Cognitive Decline Prevention in Atrial Fibrillation by Intensive Cholesterol Lowering in Elderly Patients

NCT00449410 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00449410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Silent Cerebrovascular Lesion and Cognitive Decline Prevention in Atrial Fibrillation by Intensive Cholesterol Lowering in Elderly Patients
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
October 31, 2006
Enrollment
35
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hemostasis, inflammation, magnetic resonance imaging, neuropsychology